Alterity Therapeutics Stock News

Shares in Alterity Therapeutics soared after the biotech firm disclosed promising new clinical trial data for its Parkinson's disease treatment.

- ATH434 improved motor performance and general function – - Webcast to be held this week to discuss new data and recent clinical progress – MELBOURNE, Australia and SAN FRANCISCO, Dec. 04, 2023 (

MELBOURNE, Australia and SAN FRANCISCO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to dev

MELBOURNE, Australia and SAN FRANCISCO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to dev

– ATH434-201 is a randomized, double-blind, placebo-controlled study in early-stage MSA – – Lead clinical development program enrolled 77 participants globally – MELBOURNE, Australia and SAN F

Highlights: Participant screening closed for ATH434-201 Phase 2 study Independent Data Monitoring Committee recommended the ATH434-201 Phase 2 study continue as planned Received A$4.74M cash refund un

MELBOURNE, Australia and SAN FRANCISCO, June 21, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to dev

MELBOURNE, Australia and SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative disea

Alterity Therapeutics Limited (NASDAQ:ATHE) with the stream of 7.84% also noticed, India Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) encountered a rapid change of 6.90% in the last hour of Mondays trading session. The post Bright Stock in Review: Alterity Therapeutics Limited (NASDAQ:ATHE), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) appeared first on Stocks Equity .

Alterity Therapeutics (ATHE) has added ~10% in the pre-market after announcing that the Journal of Parkinson''s Disease published data from an animal study, which was designed to

Alterity Therapeutics's ATHE data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson's Disease.  [ALERT[ Matt Maley just released his latest pick with an

Alterity Therapeutics Ltd - ADR (ATHE) shares closed this week 40.3% higher than it did at the end of last week. The stock is currently up 40.3% year-to-date, down 33.6% over the past 12 months, and down 57.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $1.23 and as low as $0.72 this week.Trading volume this week was 64.1% lower than the 10-day average and 33.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2077.1% The company's stock price performance over the past 12 months lags the peer average by 138.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Nanocap biotech, Alterity Therapeutics (ATHE) has added ~29.0% in the pre-market on above-average volume after announcing that the U.S

(RTTNews) - The following are some of the stocks making big moves in Thursday''s pre-market trading (as of 07.20 A.M. ET). In the Green Kaival Brands Innovations Group, Inc. (KAVL) is up over 39% at $0.86 Alterity Therapeutics Limited (ATHE) is up over 36% at $1.13 Plus Therapeutics, Inc. (PSTV) is up over 19% at $1.54 Siyata Mobile Inc.

These penny stocks climbed during premarket trading, here's why The post Hot Penny Stocks to Watch Right Now That Are Moving in Premarket appeared first on Penny Stocks to Buy, Picks, News and Informa